CapEdge
Loading...
Advanced
What's new? Log in Free sign up
  • Home
  • Sectors & IndustriesSectors
  • Earnings
  • IPOs
  • SPACs
  • Transcripts
  • Insider
  • Institutional
  • Crypto
  • Screeners
  • Reddit
  • Splits
  • FNA Dashboard
  • Financials
  • Filings
  • Transcripts
  • ETFs
  • Insider
  • Institutional
  • Shorts
  • News
  • Patents
  • Reddit

Paragon 28 (FNA)

Company Profile
Paragon 28®, Inc. was established in 2010 to address the unmet and under-served needs of the foot and ankle community. From the onset, Paragon 28® has made it its goal to re-invent the space of foot and ankle surgery. The companies believes that through research and innovation Paragon can create new and improved solutions to the challenges faced by foot and ankle specialists.

Company profile

Ticker
FNA
Exchange
NYSE
Website
www.paragon28.com
Employees
Incorporated
Colorado
Location
Colorado
Fiscal year end
Dec 31
Sector
Manufacturing > Surgical and Medical Instrument Manufacturing
Industry (SIC)
Surgical & Medical Instruments & Apparatus
3M • Baxter International • Boston Scientific • Stryker • Becton, Dickinson And • Teleflex • Resmed • Haemonetics • Hill-Rom • Nuvasive ...
SEC CIK
0001531978
Corporate docs
Underwriting Agreements
Indentures
Material Contracts & Credit Agreements
Subsidiaries Lists
IRS number
273170186

FNA stock data

Analyst ratings and price targets

Last 3 months
B. Riley Securities
Initiated
Buy
$32.00
14 Dec 22
Latest filings (excl ownership)
View all
8-K
Other Events
30 Jan 23
424B5
Prospectus supplement for primary offering
27 Jan 23
424B5
Prospectus supplement for primary offering
25 Jan 23
8-K
Results of Operations and Financial Condition
25 Jan 23
8-K
Paragon 28 Announces Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2022
10 Jan 23
8-K
Entry into a Material Definitive Agreement
1 Dec 22
10-Q
2022 Q3
Quarterly report
10 Nov 22
8-K
Paragon 28 Reports Third Quarter 2022 Financial Results and Increases 2022 Net Revenue Guidance
10 Nov 22
EFFECT
Notice of effectiveness
8 Nov 22
CORRESP
Correspondence with SEC
3 Nov 22
Transcripts
FNA
Earnings call transcript
2022 Q2
6 Aug 22
FNA
Earnings call transcript
2022 Q1
10 May 22
FNA
Earnings call transcript
2021 Q4
9 Mar 22
Latest ownership filings
View all
4
Albert DaCosta
1 Feb 23
3
B. AG Bird
12 Jan 23
SC 13G
Bird B. AG
12 Jan 23
4
Matthew Jarboe
27 Dec 22
4
Matthew Jarboe
23 Dec 22
4
Change in insider ownership
21 Dec 22
4
Change in insider ownership
15 Dec 22
4
Change in insider ownership
12 Dec 22
4
Albert DaCosta
2 Dec 22
4
Change in insider ownership
2 Dec 22

Financial summary

Financial statements Chart FNA financial data
Quarter (USD) Sep 22 Jun 22 Mar 22 Dec 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Dec 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Cash burn rate (est.) Burn method: Change in cash Burn method: Operating income Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 56.33 mm 56.33 mm 56.33 mm 56.33 mm 56.33 mm 56.33 mm
Cash burn (monthly) 5.56 mm (no burn) 3.17 mm 2.85 mm (no burn) 888.17 k
Cash used (since last report) 23.47 mm n/a 13.40 mm 12.02 mm n/a 3.75 mm
Cash remaining 32.86 mm n/a 42.92 mm 44.31 mm n/a 52.58 mm
Runway (months of cash) 5.9 n/a 13.5 15.6 n/a 59.2

Beta Read what these cash burn values mean

Financial data from Paragon 28 earnings reports.

Institutional ownership, Q3 2022

FNA institutional ownership history Ownership history
68.0% owned by funds/institutions
13F holders Current Prev Q Change
Total holders 79 68 +16.2%
Opened positions 18 20 -10.0%
Closed positions 7 10 -30.0%
Increased positions 29 31 -6.5%
Reduced positions 19 13 +46.2%
13F shares Current Prev Q Change
Total value 964.34 mm 1.35 bn -28.8%
Total shares 52.91 mm 52.61 mm +0.6%
Total puts 0.00 0.00
Total calls 0.00 0.00
Total put/call ratio – – –
Largest owners Shares Value Change
Bird B. 15.55 mm $275.10 mm 0.0%
MVM Partners 14.41 mm $281.37 mm 0.0%
Rosenthal Investment 7.21 mm $127.62 mm 0.0%
BLK Blackrock 2.54 mm $45.29 mm +10.1%
Wasatch Advisors 1.71 mm $30.41 mm -6.4%
Vanguard 1.39 mm $24.69 mm +21.1%
First Light Asset Management 1.24 mm $22.06 mm +0.0%
BAC Bank Of America 1.10 mm $19.52 mm -8.9%
ArrowMark Colorado 819.03 k $14.60 mm -8.3%
Skandinaviska Enskilda Banken AB 780.57 k $13.91 mm +19.9%
Largest transactions Shares Bought/sold Change
STT State Street 0.00 -886.10 k EXIT
Millennium Management 764.98 k +391.20 k +104.7%
Vanguard 1.39 mm +241.32 k +21.1%
BLK Blackrock 2.54 mm +232.71 k +10.1%
Geode Capital Management 587.77 k +163.69 k +38.6%
Skandinaviska Enskilda Banken AB 780.57 k +129.66 k +19.9%
Wasatch Advisors 1.71 mm -117.04 k -6.4%
Russell Investments 264.23 k +110.34 k +71.7%
BAC Bank Of America 1.10 mm -107.26 k -8.9%
Charles Schwab Investment Management 231.08 k +91.82 k +65.9%
Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

FNA insider ownership history Insider history
Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
30 Jan 23 Albert DaCosta Common Stock Sell Dispose S Yes No 0 500,000 0.00 100,000
30 Jan 23 Albert DaCosta Common Stock Sell Dispose S No No 17 500,000 8.50 mm 479,136
17 Jan 23 Albert DaCosta Common Stock Other Dispose J Yes No 0 1,200,000 0.00 5,280,610
23 Dec 22 Matthew Jarboe Common Stock Sell Dispose S No Yes 20.9253 35,110 734.69 k 271,764
23 Dec 22 Matthew Jarboe Common Stock Option exercise Acquire M No No 1.2 35,110 42.13 k 306,874
23 Dec 22 Matthew Jarboe Stock Option Common Stock Option exercise Dispose M No No 1.2 35,110 42.13 k 25,000
21 Dec 22 Matthew Jarboe Common Stock Sell Dispose S No Yes 20.9132 24,913 521.01 k 271,764
21 Dec 22 Matthew Jarboe Common Stock Option exercise Acquire M No No 1.2 14,890 17.87 k 296,677
21 Dec 22 Matthew Jarboe Common Stock Option exercise Acquire M No No 0.6 10,023 6.01 k 281,787
21 Dec 22 Matthew Jarboe Stock Option Common Stock Option exercise Dispose M No No 1.2 14,890 17.87 k 60,110
Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

News

From Benzinga Pro
Why Panbela Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
26 Jan 23
Gainers MicroAlgo Inc. (NASDAQ: MLGO) shares jumped 74% to $2.90. MicroAlgo recently entered into securities purchase agreement for up to $3.2 million.
12 Health Care Stocks Moving In Thursday's Intraday Session
26 Jan 23
12 Health Care Stocks Moving In Thursday's Pre-Market Session
26 Jan 23
Reported Late Wednesday, Paragon 28 Announces Pricing Of $63.8M Public Offering Of $6.5M Shares Of Common Stock At A Price Of $17/Share
26 Jan 23
12 Health Care Stocks Moving In Wednesday's After-Market Session
25 Jan 23

Press releases

From Benzinga Pro
Paragon 28, Inc. Announces Pricing of Public Offering
25 Jan 23
Paragon 28, Inc. (NYSE:FNA) ("Paragon"), a leading medical device company exclusively focused on the foot and ankle orthopedic market, announced today the pricing of the previously announced underwritten public offering
Paragon 28, Inc. Announces Proposed Public Offering of Common Stock
25 Jan 23
Paragon 28, Inc. (NYSE:FNA) ("Paragon"), a leading medical device company exclusively focused on the foot and ankle orthopedic market, announced today the commencement of a proposed underwritten public offering of
Paragon 28 Announces Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2022
10 Jan 23
Paragon 28, Inc. (NYSE:FNA) ("Paragon 28" or "P28"), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced a range of its preliminary unaudited revenue for the
Paragon 28 to Present at The 34th Annual Piper Sandler Healthcare Conference
16 Nov 22
Paragon 28 Reports Third Quarter 2022 Financial Results and Increases 2022 Net Revenue Guidance
10 Nov 22
Finsight
Resources
  • Knowledgebase
  • Log In
  • Register
Company
  • About
  • Contact
  • Solutions
Products
  • Deal Roadshow
  • DealVDR
  • Evercall
  • Finsight.com
CapEdge
  • Earnings Calendar
  • Earnings Transcripts
  • EDGAR Filing Screener
  • IPO Calendar
  • Compliance
  • Privacy
  • Security
  • Terms
AngelList LinkedIn